Homocysteine and cardiovascular disease

QJM. 1996 Aug;89(8):561-3. doi: 10.1093/qjmed/89.8.561.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • 5,10-Methylenetetrahydrofolate Reductase (FADH2)
  • Aged
  • Cardiovascular Diseases / etiology*
  • Cardiovascular Diseases / genetics
  • Cardiovascular Diseases / prevention & control
  • Diet
  • Female
  • Folic Acid / therapeutic use
  • Homocysteine / blood*
  • Homozygote
  • Humans
  • Male
  • Methylenetetrahydrofolate Reductase (NADPH2)
  • Mutation
  • Oxidoreductases / genetics
  • Oxidoreductases / metabolism
  • Risk Factors
  • Vitamin B Deficiency / complications

Substances

  • Homocysteine
  • Folic Acid
  • Oxidoreductases
  • 5,10-Methylenetetrahydrofolate Reductase (FADH2)
  • Methylenetetrahydrofolate Reductase (NADPH2)